Snippet data - viewing only, no editing possible


Label

Field name

Field value


Sitting_Date

04/16/2013 12:00:00 AM


Sitting_Forum


Snippet Ref No

SnippetRefNo

WRXX01800

Selected Quill

SnippetType

7

Saved Quill

SnippetType_C4D


Selected Quill

SnippetType_1

7

Speaker Name

IndxSpeakerName


Business Category

IndxMainHeadCat

Questions

Sub Category

IndxSubTopic

Written Answers

Topic

IndxQHeadTopic

Clinical Drug Trials

See Also

SeeAlso


Part1

TitlePart1


Part2

TitlePart2


Part3

TitlePart3


Volume

VolumeNo

799

Book No

BookNo

1

Pdf Ref

PdfPageRef

599

Default Business Index

IndexViewCategoryDefault

Questions\Written Answers\Clinical Drug Trials

3 Part Title Business Index

IndexViewCategoryTitle


Default Topic Index

IndexViewCategoryDefaultSpeaker

Clinical Drug Trials

3 Part Topic Index

IndexViewCategoryTitleSpeaker


Motion Code

MotionCode


Motion Title

MotionTitle


Stage

MotionStage


Amendment No

MotionAmendmentNo


Bill Code

BillCode


Bill Title

BillTitle


Stage

BillStage


Section

BillSection


Statement Code

StatementCode


Statement Title

StatementTitle


Stage

StatementStage


Hour Indicator

HourIndicator

Not applicable

Procedural Instruction

Procedural_Instruction

No

Debate Adjourned

DebateAdjourned

No

Question Askee

QAskee


Question Asker

QAsker


Question Department

QDept


Question ID

QID


Question Reference

QRef


Question Speaker PID

QSpeakerPID


Question Speaker PID To

QSpeakerPIDTo


Questions Asked

QUESTIONSASKED


Speaker Type

SpeakerType

2

Speaker Name

Senator


Deputy


Minister

Minister of State at the Department of Health (Deputy Alex White)

Witness


Chairman


ViceChairman


ActingChairmanD


ActingChairmanS


Speaker4Display

Speaker4Display

Minister of State at the Department of Health (Deputy Alex White)

Speaker

Speaker


SpeakerPID

SpeakerPID

AlexWhite

SpeakerText

SpeakerText

Alex White

OriginalUnidSnippet

OriginalUnidSnippet

5E256A8237E0187F80257B500062F671

LastModifiedSnippet

LastModifiedSnippet

04/29/2020 08:30:15 AM

TopicIndex1stCategoryValues

TopicIndex1stCategoryValues

Snippet Contents:

The Irish Medicines Board (IMB) is the competent authority for the authorisation of clinical trials with medicines in Ireland. However, the IMB does not carry out trials and neither does the Department of Health. Clinical trials are conducted by sponsors from industry or academia and carried out by healthcare professionals according to protocols authorised by the IMB and approved by an ethics committee.
Under European and Irish legislation, before a medicine can be placed on the Irish market the manufacturer has to seek an authorisation from the Irish Medicines Board (IMB) or in the case of certain medicinal products, the European Medicines Agency (EMA). A determination on an application for authorisation of a medicine is based on a rigorous scientific assessment of the application against legal and regulatory requirements.
Naltrexone is authorised in Ireland for the treatment of alcohol and drug dependence; it is not authorised for the treatment of multiple sclerosis or autoimmune disorders and there are currently no clinical trials authorised for these conditions in Ireland.